0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Skin Cancer Molecular Diagnostics Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-36Z5738
Home | Market Reports | Health| Health Conditions| Cancer
Global Skin Cancer Molecular Diagnostics Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Skin Cancer Molecular Diagnostics Market Research Report 2024

Code: QYRE-Auto-36Z5738
Report
February 2024
Pages:66
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Skin Cancer Molecular Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Skin Cancer Molecular Diagnostics Market

Skin Cancer Molecular Diagnostics Market

A molecular approach for diagnosing skin cancer
The global Skin Cancer Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Skin Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Cancer Molecular Diagnostics.

Report Scope

The Skin Cancer Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Skin Cancer Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Skin Cancer Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Skin Cancer Molecular Diagnostics Market Report

Report Metric Details
Report Name Skin Cancer Molecular Diagnostics Market
CAGR 5%
Segment by Type
  • PCR
  • FISH
  • DNA Sequencing
  • Gene Chip
Segment by Application
  • Clinical Diagnosis
  • Drug Screening
  • Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Inmedi, Roche, Annoroad
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Skin Cancer Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Skin Cancer Molecular Diagnostics Market report?

Ans: The main players in the Skin Cancer Molecular Diagnostics Market are Inmedi, Roche, Annoroad

What are the Application segmentation covered in the Skin Cancer Molecular Diagnostics Market report?

Ans: The Applications covered in the Skin Cancer Molecular Diagnostics Market report are Clinical Diagnosis, Drug Screening, Research

What are the Type segmentation covered in the Skin Cancer Molecular Diagnostics Market report?

Ans: The Types covered in the Skin Cancer Molecular Diagnostics Market report are PCR, FISH, DNA Sequencing, Gene Chip

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Skin Cancer Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Skin Cancer Molecular Diagnostics Market Perspective (2019-2030)
2.2 Skin Cancer Molecular Diagnostics Growth Trends by Region
2.2.1 Global Skin Cancer Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Skin Cancer Molecular Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Skin Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Skin Cancer Molecular Diagnostics Market Dynamics
2.3.1 Skin Cancer Molecular Diagnostics Industry Trends
2.3.2 Skin Cancer Molecular Diagnostics Market Drivers
2.3.3 Skin Cancer Molecular Diagnostics Market Challenges
2.3.4 Skin Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Skin Cancer Molecular Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Skin Cancer Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Skin Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Skin Cancer Molecular Diagnostics Revenue
3.4 Global Skin Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Skin Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Cancer Molecular Diagnostics Revenue in 2023
3.5 Skin Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Skin Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Skin Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Skin Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Skin Cancer Molecular Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Skin Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030)
5 Skin Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Skin Cancer Molecular Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Skin Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Skin Cancer Molecular Diagnostics Market Size (2019-2030)
6.2 North America Skin Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Skin Cancer Molecular Diagnostics Market Size by Country (2019-2024)
6.4 North America Skin Cancer Molecular Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Skin Cancer Molecular Diagnostics Market Size (2019-2030)
7.2 Europe Skin Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Skin Cancer Molecular Diagnostics Market Size by Country (2019-2024)
7.4 Europe Skin Cancer Molecular Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Skin Cancer Molecular Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Skin Cancer Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Skin Cancer Molecular Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Skin Cancer Molecular Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Skin Cancer Molecular Diagnostics Market Size (2019-2030)
9.2 Latin America Skin Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Skin Cancer Molecular Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Skin Cancer Molecular Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Cancer Molecular Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Skin Cancer Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Skin Cancer Molecular Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Skin Cancer Molecular Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Inmedi
11.1.1 Inmedi Company Detail
11.1.2 Inmedi Business Overview
11.1.3 Inmedi Skin Cancer Molecular Diagnostics Introduction
11.1.4 Inmedi Revenue in Skin Cancer Molecular Diagnostics Business (2019-2024)
11.1.5 Inmedi Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Skin Cancer Molecular Diagnostics Introduction
11.2.4 Roche Revenue in Skin Cancer Molecular Diagnostics Business (2019-2024)
11.2.5 Roche Recent Development
11.3 Annoroad
11.3.1 Annoroad Company Detail
11.3.2 Annoroad Business Overview
11.3.3 Annoroad Skin Cancer Molecular Diagnostics Introduction
11.3.4 Annoroad Revenue in Skin Cancer Molecular Diagnostics Business (2019-2024)
11.3.5 Annoroad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Skin Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of PCR
    Table 3. Key Players of FISH
    Table 4. Key Players of DNA Sequencing
    Table 5. Key Players of Gene Chip
    Table 6. Global Skin Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Skin Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Skin Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Skin Cancer Molecular Diagnostics Market Share by Region (2019-2024)
    Table 10. Global Skin Cancer Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Skin Cancer Molecular Diagnostics Market Share by Region (2025-2030)
    Table 12. Skin Cancer Molecular Diagnostics Market Trends
    Table 13. Skin Cancer Molecular Diagnostics Market Drivers
    Table 14. Skin Cancer Molecular Diagnostics Market Challenges
    Table 15. Skin Cancer Molecular Diagnostics Market Restraints
    Table 16. Global Skin Cancer Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Skin Cancer Molecular Diagnostics Market Share by Players (2019-2024)
    Table 18. Global Top Skin Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Molecular Diagnostics as of 2023)
    Table 19. Ranking of Global Top Skin Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Skin Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Skin Cancer Molecular Diagnostics Product Solution and Service
    Table 23. Date of Enter into Skin Cancer Molecular Diagnostics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Skin Cancer Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Skin Cancer Molecular Diagnostics Revenue Market Share by Type (2019-2024)
    Table 27. Global Skin Cancer Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Skin Cancer Molecular Diagnostics Revenue Market Share by Type (2025-2030)
    Table 29. Global Skin Cancer Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Skin Cancer Molecular Diagnostics Revenue Market Share by Application (2019-2024)
    Table 31. Global Skin Cancer Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Skin Cancer Molecular Diagnostics Revenue Market Share by Application (2025-2030)
    Table 33. North America Skin Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Skin Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Skin Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Skin Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Skin Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Skin Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Skin Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Skin Cancer Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Skin Cancer Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Skin Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Skin Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Skin Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Skin Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Skin Cancer Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Skin Cancer Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Inmedi Company Detail
    Table 49. Inmedi Business Overview
    Table 50. Inmedi Skin Cancer Molecular Diagnostics Product
    Table 51. Inmedi Revenue in Skin Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 52. Inmedi Recent Development
    Table 53. Roche Company Detail
    Table 54. Roche Business Overview
    Table 55. Roche Skin Cancer Molecular Diagnostics Product
    Table 56. Roche Revenue in Skin Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 57. Roche Recent Development
    Table 58. Annoroad Company Detail
    Table 59. Annoroad Business Overview
    Table 60. Annoroad Skin Cancer Molecular Diagnostics Product
    Table 61. Annoroad Revenue in Skin Cancer Molecular Diagnostics Business (2019-2024) & (US$ Million)
    Table 62. Annoroad Recent Development
    Table 63. Research Programs/Design for This Report
    Table 64. Key Data Information from Secondary Sources
    Table 65. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Skin Cancer Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Skin Cancer Molecular Diagnostics Market Share by Type: 2023 VS 2030
    Figure 3. PCR Features
    Figure 4. FISH Features
    Figure 5. DNA Sequencing Features
    Figure 6. Gene Chip Features
    Figure 7. Global Skin Cancer Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Skin Cancer Molecular Diagnostics Market Share by Application: 2023 VS 2030
    Figure 9. Clinical Diagnosis Case Studies
    Figure 10. Drug Screening Case Studies
    Figure 11. Research Case Studies
    Figure 12. Skin Cancer Molecular Diagnostics Report Years Considered
    Figure 13. Global Skin Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Skin Cancer Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Skin Cancer Molecular Diagnostics Market Share by Region: 2023 VS 2030
    Figure 16. Global Skin Cancer Molecular Diagnostics Market Share by Players in 2023
    Figure 17. Global Top Skin Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Molecular Diagnostics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Skin Cancer Molecular Diagnostics Revenue in 2023
    Figure 19. North America Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Skin Cancer Molecular Diagnostics Market Share by Country (2019-2030)
    Figure 21. United States Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Skin Cancer Molecular Diagnostics Market Share by Country (2019-2030)
    Figure 25. Germany Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Skin Cancer Molecular Diagnostics Market Share by Region (2019-2030)
    Figure 33. China Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Skin Cancer Molecular Diagnostics Market Share by Country (2019-2030)
    Figure 41. Mexico Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Skin Cancer Molecular Diagnostics Market Share by Country (2019-2030)
    Figure 45. Turkey Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Skin Cancer Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Inmedi Revenue Growth Rate in Skin Cancer Molecular Diagnostics Business (2019-2024)
    Figure 48. Roche Revenue Growth Rate in Skin Cancer Molecular Diagnostics Business (2019-2024)
    Figure 49. Annoroad Revenue Growth Rate in Skin Cancer Molecular Diagnostics Business (2019-2024)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona
OSZAR »